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ABSTRACT
PURPOSE: The increase in fructose consumption is paralleled by a higher incidence of obesity worldwide. This monosaccharide is
linked to metabolic syndrome, being associated with hypertriglyceridemia, hypertension, insulin resistance and diabetes mellitus. It is
metabolized principally in the liver, where it can be converted into fatty acids, which are stored in the form of triglycerides leading to
NAFLD. Several models of NAFLD use diets high in simple carbohydrates. Thus, this study aimed to describe the major metabolic
changes caused by excessive consumption of fructose in humans and animals and to present liver abnormalities resulting from high
intakes of fructose in different periods of consumption and experimental designs in Wistar rats.
METHODS: Two groups of rats were fasted for 48 hours and reefed for 24 or 48 hours with a diet containing 63% fructose. Another
group of rats was fed an diet with 63% fructose for 90 days.
RESULTS:  Refeeding for 24 hours caused accumulation of large amounts of fat, compromising 100% of the hepatocytes. The amount
of liver fat in animals refed for 48 hours decreased, remaining mostly in zone 2 (medium-zonal). In liver plates of Wistar rats fed 63%
fructose for 45, 60 and 90 days it’s possible to see that there is an increase in hepatocytes with fat accumulation according to the
increased time; hepatic steatosis, however, is mild, compromising about 20% of the hepatocytes.
CONCLUSIONS: Fructose is highly lipogenic, however the induction of chronic models in NAFLD requires long periods of treatment.
The acute supply for 24 or 48 hours, fasted rats can cause big changes, liver steatosis with macrovesicular in all lobular zones.
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RESUMO
OBJETIVO: O aumento do consumo de frutose é concomitante a maior incidência mundial de obesidade. Este monossacarídeo está
relacionado à Síndrome Metabólica, sendo vinculado à hipertrigliceridemia, hipertensão arterial, resistência à insulina e diabetes
mellitus. É metabolizada principalmente no fígado, onde pode ser convertida em ácidos graxos, os quais serão estocados na forma de
trigligérides ocasionando a esteatose hepática não alcoólica (NAFLD). Vários modelos de NAFLD utilizam dietas ricas em carboidratos
simples. Desta forma, este trabalho teve como objetivos descrever as principais alterações metabólicas causadas pelo consumo excessivo
de frutose em humanos e em animais e apresentar as alterações hepáticas decorrentes da alta ingestão de frutose em diferentes períodos
de consumo e desenhos experimentais em ratos Wistar.
MÉTODOS: Dois grupos de ratos Wistar foram mantidos em jejum durante 48 horas e realimentados por 24 ou 48 horas com dieta
contendo 63% de frutose. Outro grupo de ratos Wistar foi alimentado com 63% de frutose durante 90 dias.
RESULTADOS: A realimentação por 24 horas provocou acúmulo de grande quantidade de gordura. A quantidade de gordura hepática
nos animais realimentados por 48 horas diminuiu, mantendo-se principalmente nas zona 2 (medio-zonal). Em fígados de ratos Wistar
alimentados com 63% de frutose até 90 dias foi possível observar que há aumento de hepatócitos com acúmulo de gordura consequente
ao aumento do tempo, no entanto a esteatose hepática é leve (20%).
CONCLUSÕES: A frutose é altamente lipogênica, no entanto a indução de NAFLD em modelos crônicos necessita de longos períodos
de tratamento. A oferta aguda, por 24 ou 48 horas, a ratos mantidos em jejum é capaz de ocasionar grandes mudanças hepáticas, com
presença de esteatose macrovesicular em todas as zonas lobulares
Descritores: Frutose. Fígado Gorduroso. Dieta. Ratos.
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Introduction
Currently, non-alcoholic fatty liver disease (NAFLD) and
nonalcoholic steatohepatitis (NASH) are related to the increasing
causes of liver disease and mortality and morbidity linked to
diseases of the liver1. It is estimated that the prevalence of NAFLD
in developed countries reaches 10% to 24% of the population2,
depending on the diagnostic criteria used3, while the worldwide
prevalence of NASH reaches 2% to 3% of the general population3.
The difficulty in assessing the prevalence of NAFLD
includes the absence of signs and symptoms, the low sensitivity
of liver enzymes as indicators of the disease and the doubtful need
of biopsy as gold standard for diagnosis3.
The NAFLD can be defined as liver accumulation of
lipids, primarily in the form of triglycerides, without ingestion of
significant quantities of alcohol and with the exclusion of other
known causes of steatosis, as some drugs and toxins4.
The NAFLD is characterized as: type 1 - only steatosis,
type 2 - steatosis plus inflammation, type 3 - steatosis plus
hepatocellular injury and type 4 - steatosis plus sinusoidal fibrosis,
Mallory bodies or both4. The NASH is considered the most serious
form of NAFLD (types 3 and 4) and is also associated with cirrhosis
and hepatocellular carcinoma4.
The progression of NAFLD to NASH occurs on account
of damage caused by lipid peroxidation and free-radical
production5. Lipid peroxidation is accompanied by an
inflammatory response and stellate cell activation, inducing
fibrogenesis6.
Day and James7 proposed the “two hits” hypothesis to
explain the progression of steatosis to inflammation, fibrosis and
cirrhosis. The first “hit” is the steatosis, caused by imbalance
between the formation and turnover of triglycerides. It is believed
that insulin resistance (IR) affects the first “hit” of NAFLD as
follows: it activates the adipocytokines secretion by adipocytes,
alters the rate of synthesis and transport of triglycerides by
hepatocytes and increases lipolysis in adipocytes that release free
fatty acids (Non Esterified Fatty Acids - NEFA) in the portal
circulation, exposing the liver to excessive levels of NEFAs. There
is a decrease in mitochondrial function and increase in the rate of
de novo synthesis and triglyceride levels. In the presence of
NAFLD, other factors such as inflammation and increased
oxidative stress probably lead to the progression to NASH, fibrosis
and necrosis. The second “hit” is possibly caused by adipocytokines
and reactive oxygen species, which activate stellate cells and
increase fibrogenesis and lipid peroxidation8.
Oxidative stress inhibits the proliferation of mature
hepatocytes, resulting in an increase in oval cells and progenitor
cells of non-differentiated hepatocytes, the presence of both cell
types being related to the progression to fibrosis9.
It is also discussed the role of factors that stimulate the
synthesis of triglycerides, rather than only accumulation10, and this
because NEFAs, tumor necrosis factor - Į (TNF-Į ) and adiponectin
are directly linked to the progression of NAFLD to NASH.
Published studies in humans report that the increase of TNF-Į or
decrease of adiponectin are associated with increased risk of
progression of NAFLD to NASH11. TNF-Į increases the formation
of reactive oxygen species, promotes apoptosis of hepatocytes and
inflammation in the liver, while adiponectin diminishes hepatic
triglycerides accumulation by reducing the NEFA export from
adipose tissue12.
If insults are large enough to develop cirrhosis, about 33%
of patients will die or develop morbid conditions8.
The IR has an important role for development of NASH
because of participation in intracellular processes such as the loss
of the inhibitory effect of insulin on ß-oxidation. This mechanism
induces intracellular oxidative stress. Patients with NASH have
an increase in ß-oxidation and in hepatic oxidative stress. These
changes are also present in patients with liver fat accumulation
resulting from diseases such as obesity, malnutrition, intestinal
malabsorption, endocrine metabolic diseases and thyroid disorders,
but only in NASH there are mitochondrial defects in the structure13.
Mitochondria are responsible for oxidative
phosphorylation and ß-oxidation of fatty acids, processes that are
the main sources of free radicals and, together with mitochondrial
disorders, play a central role in the development of NASH6. The
mitochondrial abnormalities associated with NAFLD include
structural damage, depletion of mitochondrial DNA, decreased
activity of respiratory chain complexes and reduced mitochondrial
ß-oxidation. Electron microscopy revealed that in the presence of
NAFLD, the mitochondria are larger and bulkier, less in number
and the mitochondrial matrix has paracrystalline inclusion and
lower density14.
Moreover IR is considered as the most common risk factor
for the development of NAFLD, and this one as a hepatic
manifestation of the Metabolic Syndrome (MS), depending on the
diagnostic criteria used3.
Independently of weight gain, MS is a great predictor for
NAFLD, so important that became recognized as the hepatic
manifestation of this syndrome8, since the prevalence of MS
reaches 34% in the U.S. population, 53% in individuals with
NAFLD and more than 88% in those with NASH15,16.
This syndrome is strongly linked to steatosis, fibrosis and
cirrhosis in obese adults in part for glucose intolerance and IR.
Numerous studies have shown that obesity, type 2 diabetes
mellitus, dyslipidemia, hypertension and IR are associated with
NAFLD. It is also associated with reduced insulin sensitivity in
liver and fat tissue of liver, and throughout the body, increasing
rate of gluconeogenesis and reduced fatty acid oxidation. However,
there is still no consensus on whether the IR is cause or
consequence of steatosis8.
Many patients with NAFLD are asymptomatic. In the
absence of cirrhosis, hepatomegaly is the only physical finding in
most patients, present in more than 75% of cases3. The use of liver
biopsy for the diagnosis of NAFLD is controversial. Usual markers
of NAFLD are alanine aminotransferase (ALT) and aspartate
aminotransferase (AST), elevated levels of these being considered
as a consequence of liver damage, fatty infiltration and
inflammation. Serum levels of these enzymes are related to multiple
components of MS8.
Several studies have demonstrated the induction of
NAFLD in rats by diets with large amounts of simple
carbohydrates17,18. However, few are focused on dietary
manipulation for effective reversal of metabolic damage generated
by these diets17.
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Consumption of simple carbohydrates such as sucrose
and fructose has increased steadily over the last 20 years17. The
excess of glucose or fructose causes the synthesis of
triacylglycerols that will accumulate in the liver. This accumulation
is the cause of NAFLD1,5.
Rats fed a diet high in simple carbohydrates (SC)
developed dyslipidemia, weight gain, visceral adiposity and
reduced insulin sensitivity17. Axen et al.19 also reported higher
levels of triglycerides in obese mice fed with SC compared to those
fed a high-fat diet and, similarly, another study indicated that by
replacing fat with carbohydrates the diet contributes to weight
gain20.
Ackerman et al.1 reported the inuction of NAFLD in rats
fed by fructose as carbohydrate source. The model of experimental
induction of NAFLD through diets high in fructose is well studied,
being able to cause hypertension, hypertriglyceridemia,
hyperinsulinemia and IR in rats21. Supplementation with fructose
for six days in healthy men caused an increased fasting glucose
and endogenous glucose production22. Fructose may be the critical
component associated with the risk of obesity and heart disease,
and clinical studies confirm that sucrose, and fructose in particular,
can induce weight gain and MS features23.
Fructose consumption
The estimated consumption of fructose by the population
is difficult to achieve because their consumption is not measured
in most surveys or databases24. According to the International
Sugar Organization (Sugar Year Book. London, 2008), South
America and Oceania are the biggest consumers of sugar24.
In the U.S. population, fructose consumption before 1900
came mainly from fruit and vegetable intake of about 15g/day;
consumption increased for 24g/day in the period before World
War II; around 1977 it reached 37g/day and in 1994 55g/day15.
Tappy and Lee noted in a review that according to the Third
National Health and Nutrition Examination Survey, currently
it is estimated that fructose consumption by teenagers reaches
72.8g/day24.
The large growth in consumption of fructose is due in
great part to the development of techniques that allowed the
extraction of starch from corn, its hydrolysis into glucose and the
enzymatic isomerization of glucose to fructose, thereby producing
large-scale syrup corn (High Fructose Corn Syrup - HFCS) after
1960’s25.
The HFCS presents good stability in acidified food and
drink; being liquid, its transport and storage are easier than those
of sucrose, and being derived from corn, HFCS has become one
of the ingredients most used by food industry26. It consists of
approximately 55% fructose and 45% glucose. It is widely used in
soft drinks and processed juices. The largest consumers of fructose,
according to The Third National Health and Nutrition Examination
Survey26, are adolescents and young adults.
It is important to consider that the increased consumption
of free fructose was accompanied by a decrease in consumption
of sucrose, in which fructose is linked to glucose24. Although Bray
et al.27 proposed that the increase in obesity was directly associated
with increased consumption of HFCS, as they both grew in the
period 1960 to 2000, we must consider that during this same period
other factors also influenced the increase in obesity, such as
increased consumption of total calories and fat26.
Studies in humans with increased consumption of fructose
showed weight gain and significant increase in triglycerides,
systolic blood pressure and IR. Most of the diets provided 400 to
800kcal/day of fructose, values among the highest rates consumed
in the United States23.
Fructose metabolism
Fructose is a monosaccharide with the same chemical
formula as glucose, the difference lying in its structure. It possesses
in its second carbon a ketone group28. Figure 1 illustrates the
structural formula of glucose and fructose.
Its metabolism differs from glucose’s by not requiring
insulin to enter the cell28. Absorption occurs via a specific
transporter present in intestinal cells, the GLUT5, which increases
in quantity according to levels of dietary fructose; in the liver its
entrance occurs with GLUT2 transporter, being this transport by
facilitated diffusion and independent of sodium. This transporter
has high affinity on account of its chemical structure, existing
competition with sorbitol due to their similarity. The liver retains
at least 50% of the ingested fructose diet, and there fructose will
be phosphorylated by frutoquinase into fructose-1-phosphate,
which is then converted into glyceraldehyde and dihydroxyacetone
phosphate. Glyceraldehyde will be later converted into
glyceraldehyde-3-phosphate and participate in the de novo
synthesis of fatty acids. Another portion of these substrates will
be converted into lactate and will be part of neogluconeogenesis28.
Fructose doesn’t need phosphofructokinase to be
metabolized, differently from glucose, which undergoes negative
regulation by citrate and ATP, because they inhibit the enzyme28.
Fructokinase is the first enzyme that converts fructose, producing
fructose-1-phosphate, which will be converted to glyceraldehyde
and dihydroxyacetone phosphate by ketosis-1-phosphate
aldolase29.
There are two sources of fructose to the body, the
exogenous, supplied by the diet, and the endogenous, made from
glucose via aldose reductase. The offer of fructose by each of these
pathways depends on factors such as exogenous availability,
transport rate and activity of aldose reductase and sorbitol
dehydrogenase. These two enzymes constitute the metabolic
pathway of polyols, responsible for the formation of fructose in
the tissues; this formation is activated by hyperglycemia and forms
fructose from sorbitol in the corneas, kidneys and peripheral nerves,
for at these the excess glucose is converted to sorbitol by aldose
reductase, which generates fructose by sorbitol dehydrogenase29.
The fructose inability to stimulate insulin and leptin
acutely and to inhibit ghrelin is a factor that admittedly affects the
control of satiety in the central nervous system23. It also seems to
decrease the basal metabolic rate, because mice that drank fructose
water gained more weight than those who ate the same calories,
but from starch23.
Fructose and NAFLD
Fructose has been appointed as a factor linked to the
increase of obesity in recent decades24. Its intake is also linked to
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the severity of nonalcoholic fatty liver disease, being visible that
NAFLD patients with larger fructose consumption had increased
liver inflammation and fibrosis30. High-fructose diets constitute
an experimental model for NAFLD. The animals begin to display
characteristics of MS, including insulin resistance,
hyperinsulinemia, hypertriglyceridemia and hypertension28.
In animals, the induction of non-alcoholic fatty liver
disease through the glut of simple carbohydrates such as sucrose
and fructose, requires more time of experiment, compared to other
models. With a shorter time it is already possible to see features of
Metabolic Syndrome (MS) as the increase in dyslipidemia, insulin
secretion and plasma free fatty acids, accumulation of triglycerides
in the liver and enlarged adiposity31. On the other hand, some
studies have reported the use of such diets for periods of up to 40
weeks. When offered for a short time, about five weeks, it
constitutes a model to analyze the forms of treatment of MS, since
it is possible to observe some of its constituents, such as
dyslipidemia and increased body fat32.
Methods
This study was approved by the Ethics Committee on
Animal Research of the Faculty of Medicine of Ribeirão Preto.
We used male Wistar rats from the Animal Service Campus
USP - Ribeirão Preto and subsequently maintained in the Animal
Department of Clinical Medicine, Faculty of Medicine of Ribeirão
Preto, USP. The light-dark regime was kept constant at 12 to 12
hours and the temperature maintained at 24 ± 2º C.
All animals were handled in accordance with the
recommendations of “The Guide for the Care and Use of
Laboratory Animals” prepared by the “National Academy of
Sciences” and published by “National Institutes of Health” (NIH
publication, 1985, 140p).
The diets offered were prepared in accordance with what
recommended the American Institute of Nutrition33, with changing
of the carbohydrate source, replacing starch and sucrose by fructose
(Figure 1).
Refeeding for 24 hours caused accumulation of large
amounts of fat, compromising 100% of the hepatocytes. The
amount of liver fat in animals refed for 48 hours decreased,
remaining mostly in zone 2 (medium-zonal). Figure 3 shows liver
plates of Wistar rats fed 63% fructose for 45, 60 and 90 days. It’s
possible to see that there is an increase in hepatocytes with fat
accumulation according to the increased time; hepatic steatosis,
however, is mild, compromising about 20% of the hepatocytes.
For histological analysis, fragments of liver tissue were
cut, being kept for 24 hours in a solution of 10% buffered
formaldehyde. Shortly thereafter, this solution was replaced with
70% alcohol. After this step, the livers were immersed in paraffin
and then cut with a thickness of 4m and stained with hematoxylin-
eosin, in order to semi-quantitatively assess hepatic steatosis, which
was classified as crosses, according to Oh et al.34, with some
modifications. The degree of steatosis was associated with
morphological location (zone 1, 2 and 3) 0 (0%) 1-25% (1: little
present in zone 3), 25-50% (2: zone 3); 50-75% (3: zones 2 and 3)
and 75-100% (4: Zone 1, 2 and 3).
Results and Discussion
Figure 2 shows liver plates of Wistar rats that were fasted
for 48 hours and refed for 24 (Figure 2b) and 48 hours (Figure 2c)
with diet containing 63% fructose.
FIGURE 2 - Microphotographs of normal liver tissue (A) and animals
fasted for 48 hours and refed with high-fructose diet for 24 hours (B
and C) and 48 h (D and E). H & E, 10x
A B C
D E
FIGURE 1 - Structural formula of D-glucose and
D-fructose
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FIGURE 3 - Microphotograps of liver tissue showing histological aspects
of animals refed with high-fructose diet for 45 days (A), 60 days (B)
and 90 days (C and D). H&E, 10x (A, B and C) and 20x (D).
 
 
 
 
 
 
A B
C D
Refeeding with high-fructose diet caused a large
accumulation of liver triacylglycerols; however, with the increase
of the offer period of this diet, there were adaptive changes and
steatosis has not presented itself so markedly, although it is still
significantly present. In another study that evaluated the refeeding
with 16 grams of carbohydrates (starch and sucrose in the same
ratio) after 24 hours of fasting it was observed increase in liver
volume, though these animals have shown a lower content of
triglycerides compared to group refed with high-fat diet35.
Delzenne et al.36 also described the accumulation of
hepatic fat in animals refed for 6 hours on high carbohydrate diet
(40% sucrose and 40% starch) with the presence of mild steatosis
microvesicular mainly in zone I, while the macrovesicular steatosis
extended for the three zones.
The larger formation of acetyl-CoA by both fructose and
sucrose, when they are offered in excess, causes a higher formation
of fatty acids that will be stored in the form of triglycerides in the
liver.
A study comparing the supply of sucrose and the supply
of glucose and fructose showed that both diets were able to cause
the MS, differing in the fact that glucose plus fructose induced
higher formation of uric acid37. This is because fructose has the
particularity of inducing higher formation of uric acid, compared
to glucose and sucrose, however for this to occur in rats it is
required a treatment with oxonic acid to uricase inhibition, an
enzyme present in rats capable of converting uric acid into
allantoin37.
The fructose offered in diet to adult Wistar rats for 4
weeks, with 90 days of life, is more effective in producing the
characteristics of MS compared to rats with 28 days of life, fed for
8 weeks. In adult animals there was an increase of fat liver, white
adipose tissue, total cholesterol, HDL, LDL, triglycerides and
serum insulin. Also offering 60% fructose in the diet was more
effective than offering 10% fructose in water32.
Conclusions
The oversupply of fructose in rats facilitates the
appearance of several features of the Metabolic Syndrome.
However, the establishment of NAFLD requires more time to
experiment. This work was the first to show the effects on liver
morphology of fructose refeeding in rats maintained in fasting for
long periods. It’s interesting to highlight that this model can be
widely used in the search for metabolic targets for counteracting
the effects of excess fructose.
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